|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01093 CSPC PHARMA
Nominal 
5.690 -0.030 (-0.524%) | 2022/12 - Final RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 4,636,627 | 6,739,610 | 3,783,900 | 3,795,293 |
| Net Cash from / (used in) Investing Activities | -- | (637,326) | (2,129,513) | (2,457,193) | (3,627,871) |
| Net Cash from / (used in) Financing Activities | -- | (2,196,606) | (1,470,976) | (1,545,539) | (151,387) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 1,802,695 | 3,139,121 | (218,832) | 16,035 |
| Cash & Cash Equivalents at beginning of period | -- | 7,259,458 | 4,118,236 | 4,335,613 | 4,316,564 |
| Effect of Foreign Exchange Rate Changes | -- | (2,444) | 2,101 | 1,455 | 3,014 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 9,059,709 | 7,259,458 | 4,118,236 | 4,335,613 |
| Remarks: | Real time quote last updated: 22/09/2023 11:02 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,966,987 |
| %Change | 0.026% |
| EPS / (LPS) | RMB 0.250 |
| NBV Per Share (¥) | RMB 2.673 |